S

Synakis

1 employees

Synakis has created a vitreous substitute to transform the treatment of retinal detachment which use vitreous substitutes.

Basic info

Industry

medical equipment manufacturing

Sectors

Medical Device
Medical

Date founded

2019

Funding rounds raised

S

Synakis raised undisclosed on January 1, 2019

Investors: UTEST, University of Toronto

FAQ